140 related articles for article (PubMed ID: 7543455)
1. Blood-sparing drugs: aprotinin, tranexamic acid, and epsilon-aminocaproic acid.
Royston D
Int Anesthesiol Clin; 1995; 33(1):155-79. PubMed ID: 7543455
[No Abstract] [Full Text] [Related]
2. Pro: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery.
Body SC; Mazer CD
Anesth Analg; 2006 Dec; 103(6):1354-9. PubMed ID: 17122202
[No Abstract] [Full Text] [Related]
3. ε-Aminocaproic acid and clinical value in cardiac anesthesia.
Raghunathan K; Connelly NR; Kanter GJ
J Cardiothorac Vasc Anesth; 2011 Feb; 25(1):16-9. PubMed ID: 20870423
[TBL] [Abstract][Full Text] [Related]
4. Current status of non-transfusional haemostatic agents.
Cattaneo M; Mannucci PM
Haematologica; 1999 Jun; 84 Suppl EHA-4():120-3. PubMed ID: 10907488
[No Abstract] [Full Text] [Related]
5. The post-BART anti-fibrinolytic dilemma?
Beattie WS; Karkouti K
J Cardiothorac Vasc Anesth; 2011 Feb; 25(1):3-5. PubMed ID: 21272775
[No Abstract] [Full Text] [Related]
6. Re-evaluation of the role of antifibrinolytic therapy with lysine analogs during cardiac surgery in the post aprotinin era.
Koster A; Schirmer U
Curr Opin Anaesthesiol; 2011 Feb; 24(1):92-7. PubMed ID: 20881484
[TBL] [Abstract][Full Text] [Related]
7. Antifibrinolytics in liver transplantation.
Groenland TH; Porte RJ
Int Anesthesiol Clin; 2006; 44(3):83-97. PubMed ID: 16832208
[No Abstract] [Full Text] [Related]
8. Antifibrinolytics.
Schmarts
Acta Anaesthesiol Belg; 2003; 54(4):319-22. PubMed ID: 14719353
[No Abstract] [Full Text] [Related]
9. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
[TBL] [Abstract][Full Text] [Related]
10. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
11. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery.
Brown JR; Birkmeyer NJ; O'Connor GT
Circulation; 2007 Jun; 115(22):2801-13. PubMed ID: 17533182
[TBL] [Abstract][Full Text] [Related]
13. Clinical use of synthetic antifibrinolytic agents during liver transplantation.
Kang Y
Semin Thromb Hemost; 1993; 19(3):258-61. PubMed ID: 8362255
[No Abstract] [Full Text] [Related]
14. Hemostatic drugs.
Mannucci PM
N Engl J Med; 1998 Jul; 339(4):245-53. PubMed ID: 9673304
[No Abstract] [Full Text] [Related]
15. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery.
Breuer T; Martin K; Wilhelm M; Wiesner G; Schreiber C; Hess J; Lange R; Tassani P
Eur J Cardiothorac Surg; 2009 Jan; 35(1):167-71; author reply 171. PubMed ID: 19027313
[TBL] [Abstract][Full Text] [Related]
16. Antifibrinolytic therapy in complex spine surgery: a case-control study comparing aprotinin and tranexamic acid.
Colomina MJ; Bagó J; Vidal X; Mora L; Pellisé F
Orthopedics; 2009 Feb; 32(2):91. PubMed ID: 19301800
[TBL] [Abstract][Full Text] [Related]
17. The use of antifibrinolytic agents in total hip arthroplasty: a meta-analysis.
Gill JB; Rosenstein A
J Arthroplasty; 2006 Sep; 21(6):869-73. PubMed ID: 16950041
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery.
Jamieson WR; Dryden PJ; O'Connor JP; Sadeghi H; Ansley DM; Merrick PM
Circulation; 1997 Nov; 96(9 Suppl):II-96-100; discussion II-100-1. PubMed ID: 9386082
[TBL] [Abstract][Full Text] [Related]
19. Low dose aprotinin and low dose tranexamic acid in elective cardiac surgery with cardiopulmonary bypass.
Waldow T; Krutzsch D; Wils M; Plötze K; Matschke K
Clin Hemorheol Microcirc; 2009; 42(4):269-77. PubMed ID: 19628892
[TBL] [Abstract][Full Text] [Related]
20. [Effects of topical applications of aprotinin and tranexamic acid on blood loss after open heart surgery].
Yasim A; Aşik R; Atahan E
Anadolu Kardiyol Derg; 2005 Mar; 5(1):36-40. PubMed ID: 15755701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
